Vita Life Sciences continues share buy-back program

Vita Life Sciences Limited (VLS) has provided a daily update on its on-market buy-back program, announcing that on October 14, 2025, it bought back an additional 12,824 securities. This latest transaction brings the total number of securities bought back to 239,268. The total consideration paid for the securities on the previous day amounted to AUD 30,913.19, with the highest price paid being AUD 2.40 and the lowest AUD 2.38.

The buy-back, which commenced on May 22, 2025, is scheduled to conclude on May 21, 2026. Vita Life Sciences intends to buy back a maximum of 8,277,101 securities, with 8,025,009 securities remaining to be bought back as of the end of the previous day. Shaw and Partners is the designated broker facilitating the buy-back.

The highest price allowed to be paid by the entity on the previous day under listing rule 7.33 was AUD 2.56. The buy-back is for a cash consideration, and the currency for the buy-back consideration is the Australian Dollar. No security holder approval is required for this ongoing buy-back program.